Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Nelson

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|October 30, 1992
Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypesP S Portoghese, M Sultana, W L Nelson, et al.
AIDS Care|April 1, 1997
HIV antibody testing: Genito-Urinary Clinic or additional site same-day testing serviceM M Hudson, W L Nelson, C J Ronalds, et al.
Life Sciences|January 1, 1988
Alteration in the disposition and metabolism of S(-)-propranolol in rats with active respiratory viral infectionE C Kwong, S Laganière, J L Savitch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomesM Kim, D D Shen, A C Eddy, et al.
Journal of Medicinal Chemistry|February 1, 1990
Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexolL D Olsen, P Klein, W L Nelson, et al.
Journal of Medicinal Chemistry|December 1, 1984
Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligandG A Koolpe, W L Nelson, T L Gioannini, et al.
American Journal of Ophthalmology|November 15, 1986
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985W L Nelson, F T Fraunfelder, J M Sills, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1976
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metaboliteJ R Mitchell, W L Nelson, W Z Potter, et al.
Biochemical Pharmacology|October 1, 1990
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprololS S Murthy, H U Shetty, W L Nelson, et al.
Journal of Pharmaceutical Sciences|November 1, 1970
Muscarinic receptors: 4-substituted-3-trimethyl-ammoniumtetrahydrofuran halidesW L Nelson, J K Wong, F F Vincenzi, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|October 30, 1992
Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypesP S Portoghese, M Sultana, W L Nelson, et al.
AIDS Care|April 1, 1997
HIV antibody testing: Genito-Urinary Clinic or additional site same-day testing serviceM M Hudson, W L Nelson, C J Ronalds, et al.
Life Sciences|January 1, 1988
Alteration in the disposition and metabolism of S(-)-propranolol in rats with active respiratory viral infectionE C Kwong, S Laganière, J L Savitch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomesM Kim, D D Shen, A C Eddy, et al.
Journal of Medicinal Chemistry|February 1, 1990
Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexolL D Olsen, P Klein, W L Nelson, et al.
Journal of Medicinal Chemistry|December 1, 1984
Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligandG A Koolpe, W L Nelson, T L Gioannini, et al.
American Journal of Ophthalmology|November 15, 1986
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985W L Nelson, F T Fraunfelder, J M Sills, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1976
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metaboliteJ R Mitchell, W L Nelson, W Z Potter, et al.
Biochemical Pharmacology|October 1, 1990
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprololS S Murthy, H U Shetty, W L Nelson, et al.
Journal of Pharmaceutical Sciences|November 1, 1970
Muscarinic receptors: 4-substituted-3-trimethyl-ammoniumtetrahydrofuran halidesW L Nelson, J K Wong, F F Vincenzi, et al.
Pageof 13